Annovis BioAdvance News Portfolio News

Annovis Awarded $1.7 Million NIH Grant for ANVS401 Chronic Toxicology Studies

By WebmasterFebruary 27, 2020November 1st, 2024No Comments

Annovis Awarded $1.7 Million NIH Grant for ANVS401 Chronic Toxicology Studies

Previous PostPillo Health Launches Pillo Remotely, a Population Health Data and Device Manager to Improve Engagement & Visibility into In-Home Health Habits
Next PostThis isn't a 'biotech bubble,' it's 'Philadelphia's moment' to become a center for gene therapy, says Penn-based CEO